<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Takeda Pharmaceutical Company Ltd. | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html?i=6]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Takeda Pharmaceutical Company Ltd.]]></description>
	<s:counts start="0" returned="10" found="49" />
	<language>en-us</language>
	<item>
		<title><![CDATA[AMITIZA®  8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_27/ai_n25455276]]></link>
		<description><![CDATA[AMITIZA 8 mcg dose is the only widely available FDA-approved prescription medication for Irritable Bowel Syndrome with Constipation  BETHESDA, Md. & DEERFIELD, Ill. -- Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) and Takeda Pharmaceuticals North America, Inc. today announced that AMITIZA([R]) lubiprostone 8 mcg capsules are now available by prescription in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 27 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome With Constipation in Adult Women]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200805/ai_n25460269]]></link>
		<description><![CDATA[Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Takeda Pharmaceuticals North America, Inc. today announced that AMITIZA® lubiprostone 8 mcg capsules are now available by prescription in pharmacies across the U.S. for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in women 18 years and older.  AMITIZA 24 mcg capsules...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 27 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Affymax® Reports Year End 2007 Financial Results]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_13/ai_n24920841]]></link>
		<description><![CDATA[PALO ALTO, Calif. -- Affymax, Inc. (Nasdaq:AFFY) today reported financial results for the year ended December 31, 2007. The net loss for the year 2007 was $43.1 million compared to a net loss of $48.3 million for the year ended December 31, 2006.  Affymax recognized revenue for the year...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/affymax+inc..html"><![CDATA[Affymax Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AFFY</category>
		<category domain="tickers">AFFY</category>
	</item>
	<item>
		<title><![CDATA[Affymax Affirms Progress with Takeda Collaboration]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Feb_5/ai_n24248260]]></link>
		<description><![CDATA[PALO ALTO, Calif. -- Affymax, Inc. (Nasdaq:AFFY) today affirmed its ongoing collaboration with Takeda Pharmaceutical Company Limited for the global development and commercialization of Hematide[TM], Affymax's lead product candidate for the treatment of anemia, continues to progress as planned.  "Our partnership is unrelated to Takeda's recently announced agreement with...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 05 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200712/ai_n21135716]]></link>
		<description><![CDATA[A new study presented today showed that ramelteon did not exacerbate respiratory depressant effects in patients (40 years and older) with moderate to severe chronic obstructive pulmonary disease COPD, as measured by oxygenation or abnormal breathing events relative to placebo.  Results of this double-blind, placebo-controlled trial were presented at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 03 Dec 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[MEDIA ADVISORY: Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL With ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200711/ai_n21084485]]></link>
		<description><![CDATA[What and When  Additional results from the clinical trial, CHICAGO (Carotid intima-media tHICkness in Atherosclerosis using pioGlitazOne), will be presented as an oral session at the American Heart Association Scientific Sessions 2007 being held November 4 through 7, 2007 in Orlando, Florida.  Results revealed that reduced progression of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 06 Nov 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA["Move to AMITIZA" Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200711/ai_n21084906]]></link>
		<description><![CDATA[Takeda Pharmaceuticals North America, Inc. and Sucampo Pharmaceuticals, Inc. today announced the launch of the first direct-to-consumer DTC advertising campaign for AMITIZA® lubiprostone, the only commercially available prescription treatment for Chronic Idiopathic Constipation in adults.  The "Move to AMITIZA" campaign illustrates that the predictable relief (defined as 57%-63% had...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 06 Nov 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients With Type 2 Diabetes]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200709/ai_n19524808]]></link>
		<description><![CDATA[Results presented today at the 43rd Annual Meeting of the European Association for the Study of Diabetes demonstrate the ability of ACTOS® pioglitazone HCl to reduce the risk of ischemic cardiovascular disease in patients with type 2 diabetes.  ACTOS is an oral antidiabetic agent for type 2 diabetes belonging...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200709/ai_n23652880]]></link>
		<description><![CDATA[BETHESDA, Maryland, September 13 /PRNewswire/ --    - First Patient Enrolled in Pivotal Studies    Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) and Takeda  Pharmaceuticals North America, Inc. today announced that the first  patient has been enrolled in a Phase III study of lubiprostone (24 mcg,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pivotal+corp..html"><![CDATA[Pivotal Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/sucampo+pharmaceuticals+inc..html"><![CDATA[Sucampo Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCMP</category>
		<category domain="tickers">SCMP</category>
	</item>
	<item>
		<title><![CDATA[Danish pharmaceutical company H Lundbeck A/S signs cooperation agreement with Japan's Takeda Pharmaceutical Company Limited]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0HXI/is_2007_Sept_5/ai_n25011377]]></link>
		<description><![CDATA[NORDIC BUSINESS REPORT-5 September 2007-Danish pharmaceutical company H Lundbeck A/S signs cooperation agreement with Japan's Takeda Pharmaceutical Company LimitedC1994-2007 M2 COMMUNICATIONS LTD http://www.m2.com  Danish pharmaceutical company H Lundbeck A/S announced on Wednesday (5 September) a strategic alliance with Japan's Takeda Pharmaceutical Company Limited.  The companies will cooperate in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 05 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/takeda+pharmaceutical+company+ltd..html"><![CDATA[Takeda Pharmaceutical Company Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
